An update on the management and outcomes of cancer patients with severe aortic stenosis.
Michael SchechterDinu Valentin BalanescuTeodora DonisanTariq J DayahBiswajit KarIgor GregoricDana E GizaJuhee SongJuan Lopez-MatteiPeter KimSerban Mihai BalanescuMehmet CilingirogluKonstantinos P ToutouzasRichard W SmallingKonstantinos MarmagkiolisCezar A IliescuPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2018)
Patients with cancer and severe AS who underwent AVR, predominantly TAVR, experienced better survival than those who had no AVR regardless of cancer type or cancer treatment. TAVR may be considered in patients with cancer and AS.
Keyphrases
- aortic stenosis
- transcatheter aortic valve replacement
- aortic valve
- ejection fraction
- aortic valve replacement
- transcatheter aortic valve implantation
- left ventricular
- coronary artery disease
- early onset
- papillary thyroid
- squamous cell carcinoma
- skeletal muscle
- atrial fibrillation
- metabolic syndrome
- insulin resistance